|
|
|
|
Vol. 19, Issue 5, 1962-1975, May 2008
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


*Life Sciences Institute and Departments of Molecular, Cellular, and Developmental Biology and Biological Chemistry,
Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109; and
Banting and Best Department of Medical Research and Department of Molecular Genetics, University of Toronto, Toronto, Ontario M5S 3E1, Canada
Submitted September 12, 2007;
Revised February 1, 2008;
Accepted February 8, 2008
Monitoring Editor: Benjamin Glick
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Autophagy starts when the intended cargo is surrounded by a double-membrane vesicle, an autophagosome. In starvation conditions, the cargo is bulk cytoplasm. Next, the autophagosome fuses with the lysosome, in mammalian cells, or the vacuole, in yeast. As a result, the autophagosome cargo is released into the organelle lumen and degraded by lysosomal/vacuolar resident hydrolases; the resulting products are subsequently recycled by release back into the cytosol (Shintani and Klionsky, 2004a
; Yang et al., 2006
).
Analysis in the yeast Saccharomyces cerevisiae has revealed the presence of selective autophagic pathways that target specific cargos, in addition to nonspecific bulk autophagy. These selective pathways morphologically resemble bulk autophagy. An example of a selective autophagy-related process is the cytoplasm-to-vacuole targeting (Cvt) pathway (Baba et al., 1997
; Scott et al., 1997
). In contrast to starvation-induced autophagy, this is a biosynthetic route, and it occurs constitutively in growing conditions. The Cvt pathway is used by the cell to deliver the precursor form of aminopeptidase I (prApe1), and a second resident hydrolase,
-mannosidase, to the vacuole. These two enzymes are transported to the vacuole in a double-membrane vesicle called a Cvt vesicle. The Cvt vesicle is
150 nm in diameter, which is much smaller than the size of autophagosomes (300–900 nm in diameter). Similar to the process of starvation-induced autophagy, the vesicle fuses with the vacuole to release the cargo. Once inside the vacuolar lumen, prApe1 is processed to the mature, fully active hydrolase. Many other examples of selective autophagy have also been described, including specific organelle degradation and the elimination of pathogenic microbes (Dunn et al., 2005
; Birmingham and Brumell, 2006
; Colombo et al., 2006
; Kissova et al., 2007
; Zhang et al., 2007
).
Approximately 30 autophagy-related (ATG) genes have been identified, predominantly in S. cerevisiae; however, the orthologues of many of the yeast Atg proteins have been found in higher eukaryotes (Klionsky et al., 2003
; Levine and Klionsky, 2004
). The general process of autophagic degradation has been explored through genetic, cell biological, and biochemical studies. Nevertheless, many aspects of this process still have to be unraveled. For example, the molecular mechanism underlying nucleation of the autophagic sequestering vesicle remains largely unknown.
Many processes involving membrane rearrangement and movement, such as endocytosis, organelle inheritance or membrane ruffling, require the cytoskeleton. Similarly, pharmacological studies have suggested a function for cytoskeletal elements in mammalian autophagy (Aplin et al., 1992
; Seglen et al., 1996
). Recently, we showed that actin is needed for the selective Cvt pathway (Reggiori et al., 2005a
). In conditional actin mutants, or in cells treated with the actin depolymerizing drug latrunculin A, Atg9 cycling is defective. An intriguing question is how actin, and associated factors, regulates the anterograde transport of Atg9 from peripheral sites in the cell to the site of vesicle formation, the phagophore assembly site (PAS). In this study, we discovered that actin-related proteins, comprising the Arp2/3 complex, are required for proper Atg9 function.
The Arp2/3 complex proteins function as nucleators of branched actin filaments, and these proteins are highly conserved through all eukaryotes, including humans (Pinyol et al., 2007
; Pollard, 2007
). Actin nucleation by the Arp2/3 complex is critical for initial steps of newly formed endocytic vesicle movement. In addition, this complex is involved in intracellular organelle (e.g., mitochondria) transport (Boldogh et al., 2003
, Fehrenbacher et al., 2004
) as well as being used as a force generator for the movement of invading bacteria inside the host cell (e.g., Listeria monocytogenes and Shigella flexneri) (Boldogh et al., 2001
; Welch et al., 1998
). The Arp2/3 complex consists of seven subunits: Arp2, Arp3, Arc15/p15, Arc18/p18/p21, Arc19/p19, Arc35/p35, and Arc40/p40. Arp2 and Arp3 are highly similar to the primary actin protein Act1,
46 and 39%, respectively, and they are proposed to directly nucleate actin polymerization in the same way that Act1 monomers are assembled into F-actin polymers (actin filaments). The primary logic behind this assumption is the sequence and structural similarity of Arp2 and Arp3 to conventional actin, especially at the barbed end-forming nucleus, which is important for initiation of actin polymerization (Pollard, 2007
).
Our studies showed that mutations in genes encoding subunits of the Arp2/3 complex interfered with Atg9 function in growing conditions. This is consistent with the previous finding that an intact cytoskeletal network is essential for the Cvt pathway, but not for bulk autophagy (Reggiori et al., 2005a
). In addition, we found that in arp2-1 mutant cells Atg9 movement was severely compromised; Atg9 was unable to localize to prApe1, suggesting a role for Arp2 in directing or regulating Atg9 movement to the cargo. Here, we propose that actin nucleation by the Arp2/3 complex promotes Atg9 movement, and the remodeling of actin structures serves as a scaffold that is necessary for the function of autophagic membranes under vegetative growth conditions.
| MATERIALS AND METHODS |
|---|
|
|
|---|
|
Plasmids
To generate a strain expressing fluorescently tagged Atg9, the ATG9 gene was amplified by PCR from genomic DNA digested with XhoI and BamHI and cloned into the XhoI and BamHI sites of the integration vector pPG5-3xGFP (Boyd et al., 2004
). The resulting plasmid, pATG9-3GFP(306), was linearized by digestion with BglII, and it was integrated at the ATG9 genomic locus. To tag Arp2 with DsRed, the ARP2 open reading frame was amplified from genomic DNA and first cloned into pSNA3416 (Reggiori and Pelham, 2001
) by using HindIII and BamHI sites. This generated ARP2 under the control of the TPI1 promotor. Next, the TPI-ARP2 fragment was excised by digestion with XhoI and BamHI and introduced into the pRS305-3DsRed vector, which was created by cloning a BamHI–NotI fragment containing triple DsRed from pDsRed.M1x3 (a generous gift from Dr. Benjamin Glick, University of Chicago) into pRS305. The resulting integrative plasmid pTPIARP2-3DsRed(305) was linearized by digestion with EcoRI, and then it was integrated into the LEU2 gene locus.
To delete the ATG11, ATG1, and ATG9 genes, the entire coding regions were replaced by the Esherichia coli kanr or Schizosaccharomyces pombe HIS3 or LEU2 genes, respectively, by using PCR primers containing 60 bases of identity to the regions flanking the open reading frames. For the ATG1 gene disruption, the BamHI–ClaI fragment was cut from p
atg1-URA (Abeliovich et al., 2003
) and integrated into the ATG1 locus.
To generate two-hybrid selection plasmids, the ARP2 gene was cloned into pGBDU-C1 and pGAD-C1 vectors by using BamHI and SalI sites to generate the plasmids pGBDU-ARP2 and pGAD-ARP2, respectively. The two-hybrid plasmids pGBDU-ATG9 and pGAD-ATG9 have been described previously (Reggiori et al., 2005b
).
The plasmids pAPG9(416), pATG1ts(414), pGFPAUT7(414), pGFPAUT7(416), and pRFPApe1(305) were described previously (Guan et al., 2001
; Suzuki et al., 2001
; Shintani et al., 2002
; He et al., 2006
).
Fluorescence Microscopy
Cells expressing fusion proteins with fluorescent tags were grown in SMD medium to mid-log phase. Fluorescence signals were visualized on a wide-field fluorescence inverted microscope (IX-70; Olympus America, Mellville, NY) equipped with a 100x oil numerical aperture (NA) 1.4 objective lens, and red fluorescent protein (RFP) and fluorescein isothiocyanate (FITC) filters. The images were captured by a Photometrix CoolSnap HQ camera (Photometrics, Tucson, AZ), and they were deconvolved using DeltaVision software (Applied Precision, Issaquah, WA).
For live-cell imaging, an ultrasensitive epifluorescence microscope (Nikon TE2000U-based dual camera system; 60x water immersion NA 1.2 objective lens) configured for high-speed acquisition of time-lapsed three-dimensional data were used. The dual charge-coupled device cameras (Cascade 2 cooled; Photometrics) and the filters were controlled by MetaMorph software (Molecular Devices, Sunnyvale, CA). The mid-log grown cells were immobilized on 1 mg/ml concanavalin A (Con A; Sigma-Aldrich, St. Louis, MO)-coated, acid-washed no. 1.5 coverglasses (Fisher Scientific, Pittsburgh, PA) mounted in a Leiden chamber (Harvard Apparatus, Cambridge, MA) as follows. An aliquot of the mid-log grown culture was added on the coverglass coated with Con A. After 2–3 min, the majority of the cells were adhered to the surface of Con A. The rest of the cells that did not attach were gently washed away with distilled water. The immobilized cells on the coverglass were placed into the Leiden chamber and covered with 1 ml of SMD medium. For the four-dimensional (4D) imaging, a Z-stack of seven optical sections spanning the entire cell was acquired either every 2 s or 10–20 s. The optical sections for each Z-stack were then collapsed to generate a two-dimensional-sum projection. The data were processed using ImageJ software (http://rsb.info.nih.gov/ij/).
Protein A Affinity Isolation
Cells were grown to OD600 = 0.8 in SMD. Cells (the equivalent of 30 ml at OD600 = 1.0) were harvested and resuspended in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM KCl, 5 mM MgCl2, 0.5% Nonidet-P40, 1 mM phenylmethylsulfonyl fluoride, and protease inhibitor cocktail). The detergent extracts were incubated with immunoglobulin (Ig)G-Sepharose beads for 2 h at 4°C. The beads were washed with lysis buffer six times and eluted in SDS-polyacrylamide gel electrophoresis (PAGE) sample buffer by incubating at 55°C for 15 min. The eluates were resolved by SDS-PAGE and immunoblotted with Atg9 antiserum or anti-protein A antibody.
Additional Assays
The pulse-chase analysis, GFP-Atg8 and Pex14-GFP processing assays, actin cytoskeleton staining with Texas Red-X phalloidin (TR phalloidin), and two-hybrid selection were carried out as described previously (Scott et al., 1997
; Kim et al., 2001
; Shintani and Klionsky, 2004b
; Reggiori et al., 2005
a). The western blots were quantified using ImageJ software.
Reagents
Antiserum to Ape1 was described previously (Klionsky et al., 1992
). The anti-GFP monoclonal antibodies are from Covance Research Products (Princeton, NJ). SuperSignal West Pico Chemiluminescent Substrate was from Pierce Chemical (Rockford, IL). All other reagents were from Sigma-Aldrich or Fisher Scientific unless specified otherwise.
| RESULTS |
|---|
|
|
|---|
Ape1 maturation in the ts mutants was assessed by pulse-chase radiolabeling. The cells were grown to early log phase at a permissive 24°C temperature and shifted for 30 min to a nonpermissive temperature of 37°C before the addition of a radioactive label. After a 10-min pulse, a portion of the cell culture was subjected to a nonradioactive chase for 3 h at 37°C, and a final part of the culture was then incubated for 3 more h at 24°C (Figure 1A). When cells were incubated at the permissive temperature, essentially all of prApe1 was converted to the mature form, Ape1, by the end of a 3-h chase. In contrast, at the nonpermissive temperature, the conditional arp2H330L mutant (hereafter referred to as arp2-1) displayed a strong defect in prApe1 maturation in growing conditions, with essentially all of the protein present as the precursor form (3-h time point in Figure 1A). We also examined cells treated with rapamycin to induce autophagy and observed a similar result; although autophagy is generally considered to be nonselective, import of prApe1 after rapamycin treatment or during starvation still occurs through a selective mechanism (Yorimitsu and Klionsky, 2005
). Precursor Ape1 maturation was restored in arp2-1 cells after shifting back to 24°C, suggesting that the defect seen at the nonpermissive temperature was not due to loss of cell viability. These results suggest that the arp2-1 mutant is defective for the specific Cvt pathway.
|
mutant, which displayed a complete block in autophagy (Figure 1B). Thus, we concluded that bulk autophagy is only partially blocked in the arp2-1 mutant. This finding is in agreement with our previous studies that indicated a requirement for actin function primarily in selective, but not bulk, autophagy (Reggiori et al., 2005a
Because the defect in GFP-Atg8 processing in the conditions that induce bulk autophagy was less evident, we decided to focus our study on selective types of autophagy. Therefore, in addition to the Cvt pathway, we examined whether any other types of selective autophagy were affected by the conditional arp2-1 allele. Selective peroxisome degradation (pexophagy) is induced when cells are grown in conditions that induce massive peroxisome proliferation, and then they are shifted to conditions where peroxisomes are no longer needed for growth. The peroxisomal membrane protein Pex14 fused to GFP can be used as a marker to monitor peroxisome degradation, similar to GFP-Atg8 (Reggiori et al., 2005a
). Free GFP was generated from arp2-1 mutant cells at the permissive temperature (Figure 1C). In contrast, Pex14-GFP processing in arp2-1 cells was completely blocked at a nonpermissive temperature, indicating a defect in pexophagy.
To verify the mutant phenotype of arp2-1, in particular the alteration of actin cytoskeleton, the latter was examined by the TR phalloidin actin-staining assay (Figure 1D). TR phalloidin is a fluorescent dye that associates with actin filaments and stains all filamentous actin structures in the cell. After staining, both actin cables and patches can be visualized by fluorescence microscopy. At 24°C, no difference was observed in actin organization between mutant and wild-type cells. In contrast, at 37°C, the mutant cells showed an abnormal actin distribution compared with wild-type cells; the cables were much less visible and the patches were more randomly distributed at the plasma membrane and they did not display as highly a polarized bud localization as seen in the wild type, where cortical actin patches are more concentrated at the site of growth. The mutant phenotype of arp2-1 that we observed at the nonpermissive temperature was consistent with previous reports. Finally, we sequenced the arp2-1 genomic locus after amplification by PCR, and we verified the presence of the mutation that alters the codon for histidine at position 330 to leucine (data not shown).
Localization of Atg9 Is Altered in the arp2-1 Conditional Mutant
In contrast to other Atg proteins that are restricted to the perivacuolar vesicle nucleation site (the PAS), Atg9 localizes to multiple punctate structures. In wild-type cells, one of the Atg9 puncta corresponds to the PAS, whereas the other sites are peripheral to this structure; Atg9 cycles between the peripheral sites and the PAS (Reggiori et al., 2005b
), possibly providing lipids to the forming autophagosomes or Cvt vesicles (Reggiori and Klionsky, 2005
). The retrograde movement (from the PAS) of Atg9 requires the Atg1–Atg13 complex, Atg2, Atg18, and the phosphatidylinositol 3-kinase complex. In contrast, the actin cytoskeleton is required for the anterograde transport (to the PAS) of Atg9 (Reggiori et al., 2005a
). Because Arp2 is an actin-related protein that is involved in intracellular trafficking we decided to test whether there was any defect in Atg9 cycling in the arp2-1 mutant. For this reason, we used the Transport of Atg9 after Knocking out ATG1 (TAKA) assay (Cheong et al., 2005
). This is an epistasis assay that examines the effect of a second mutation relative to atg1
with regard to Atg9 movement to the PAS; in atg1
cells, Atg9 is confined to the PAS.
We examined atg1
cells that harbored a plasmid encoding a temperature-sensitive allele of ATG1. This strain was chromosomally tagged with Atg9-3xGFP and RFP-Ape1; the tagged prApe1 was used to mark the location of the PAS. At the permissive temperature Atg9-3xGFP was seen in multiple dots, and one of them coincided with the RFP-Ape1 PAS marker (Figure 2A). When the atg1ts cells were shifted to nonpermissive temperature, Atg9-3xGFP fluorescence collapsed into a single punctum, which completely colocalized with RFP-Ape1, similar to the result seen in atg1
cells (Reggiori et al., 2005b
). In double mutant arp2-1 atg1ts cells, at the permissive temperature, the Atg9-GFP fluorescence pattern looked the same as in atg1ts cells. In contrast, at the nonpermissive temperature Atg9-3xGFP was excluded from the PAS, a phenotype that was clearly distinct from cells that harbored only the atg1
deletion (Figure 2B). Hence, Atg9 did not localize to the PAS in the arp2-1 conditional mutant when Atg1 was inactive, and we conclude that the trafficking of Atg9 to the PAS depends on Arp2 function; that is, Arp2 function was epistatic to that of Atg1.
|
0.05). Although some of the Atg9-3xGFP dots in the arp2-1 strain appeared and/or disappeared over the time course of the analysis, we think these corresponded to puncta that were moving into and out of the focal plane due to Brownian motion; however, we cannot rule out the possibility that some of the puncta in the mutant strain displayed movement. Overall, it was clear that the majority of the dots in the arp2-1 strain were not changing location or that their velocities were significantly reduced compared with the wild-type strain. Therefore, we conclude that the movement of Atg9 at the peripheral sites was compromised in the arp2-1 conditional mutant.
|
|
strain background, as well as Arp2-3xDsRed and Vrg4-GFP colocalization in the wild-type background, and we carried out a statistical analysis. In the atg1
strain, Atg9 was mostly restricted to a single perivacuolar dot, which did not show colocalization with any of the multiple Arp2 puncta (Figure 4A). We chose to analyze Vrg4 because it is an integral membrane protein, as is Atg9, which localizes to the Golgi complex; there is no indication that Arp2 specifically localizes to the Golgi, and Vrg4 therefore serves as a nonspecific marker protein. Vrg4 chromosomally tagged with GFP was also present in multiple dots, the number of puncta being similar to Atg9-GFP; however, we found that it did not colocalize with Arp2 in wild-type cells (Figure 4A). Our statistical analysis revealed that the number of Arp2 puncta that colocalized with Atg9 in the wild-type strain (
14%) was significantly higher than the number of dots of Arp2 that colocalized either with Vrg4 in the wild-type strain or with Atg9 in the atg1
strain (Figure 4C). Finally, we verified that the chimeric Arp2 and Atg9 proteins, with C-terminal fusions to 3xDsRed or 3xGFP, respectively were functional; Arp2 fused to 3xDsRed revealed normal cellular distribution as it was colocalized with GFP-tagged Abp1, a marker for actin patches (our unpublished data). In addition, the cell morphology and actin cytoskeleton organization were normal and the cells grew at rates similar to wild-type cells at 24°C as well as at 37°C (our unpublished data). Finally, both chimeras complemented arp2-1 or atg9
mutant strains, respectively, for maturation of prApe1 (Figure 4, D and E).
Arp2 Interacts with Atg9
The fluorescence microscopy data suggest that Atg9 and Arp2 transiently colocalize. Accordingly, we decided to examine whether these proteins interact. To this end, we first performed a yeast two hybrid-based analysis. We found that yeast two-hybrid cells harboring plasmids encoding Arp2 and Atg9 showed growth on plates lacking histidine but not on plates lacking adenine, indicating that Arp2 could interact weakly with Atg9 under the conditions of this assay (our unpublished data). To further clarify the physiological significance of the Atg9–Arp2 interaction, we decided to test the interaction using a biochemical approach. The functionality of the chromosomally tagged Arp2 was verified by a prApe1 maturation assay (our unpublished data). Wild-type, atg1
, and atg11
cells expressing chromosomally TAP-tagged Arp2 and endogenous Atg9 were lysed, and the TAP-tagged protein was isolated with IgG-Sepharose beads. The presence of Arp2-TAP and Atg9 was detected by immunoblotting with anti-Atg9 antibody.
Approximately 25 ± 7% (n = 3) of the Atg9 pool was coimmunoprecipitated with Arp2-TAP, which suggests that the two proteins interact at a moderate level (Figure 5A). Nonetheless, this level of interaction was substantially higher than we expected based on our fluorescence microscopy data, which revealed that only a very small proportion of Atg9 puncta showed any colocalization with Arp2 (Figure 4). To investigate the nature of this apparent discrepancy, we repeated the affinity isolation with a strain harboring a centromeric plasmid allowing expression of ATG9 from an endogenous promoter but at a higher level, and we found a substantial increase in the amount of Atg9 protein bound to Arp2 (our unpublished data). Increasing the incubation time for the coimmunoprecipitation of the cell lysate gave a similar result (our unpublished data). Thus, the amount of Atg9 bound to Arp2 seems to be affected by the expression level and experimental conditions; Arp2 may bind a higher level of Atg9 during the in vitro affinity isolation, perhaps due to a loss of regulation that normally occurs in vivo. To verify the interaction between these two proteins, we repeated the affinity isolation in the reverse direction, using Atg9 tagged with protein A to coprecipitate Arp2-GFP. In this case, we detected a very weak, but reproducible, interaction between the two proteins (Figure 5B).
|
strain (Figure 5C). This result suggests that Arp2 is not localized at the PAS or that the two proteins do not interact at this site. Similarly, we did not detect an interaction between these two proteins in an atg11
strain (Figure 5C). The latter result was interesting because Atg11 is required for transit of Atg9 from the peripheral sites to the PAS (He et al., 2006
cells or when Atg9 cycling is blocked in atg11
cells. In addition, these results are consistent with our fluorescence microscopy data, which showed that the two proteins do not colocalize when Atg9 is restricted to a single PAS dot in atg1
cells.
For atg1
cells, Atg9 is localized in a distinct site separate from Arp2; however, this is not the case in an atg11
strain. Accordingly, because of the lack of interaction in the atg11
cells, we hypothesized that the interaction of Atg9 with Arp2 might be dependent on Atg11. To test this, we examined the interaction in the Atg9H192L mutant, in which the codon for histidine at position 192 was altered to leucine; this mutation causes loss of interaction between Atg9 and Atg11 (He et al., 2006
), and we asked the question of whether the loss of Atg9–Atg11 interaction affected the interaction between Atg9 and Arp2. First, we tested the Atg9–Arp2 interaction by coimmunoprecipitation, and we found that Atg9H192L was essentially not coimmunoprecipitated with Arp2-TAP (Figure 6A). Next, we performed a time-lapse experiment and examined Atg9 and Arp2 colocalization in strains expressing either wild-type Atg9 or Atg9H192L tagged with 3xGFP (Figure 6B). We used wide-field real-time microscopy with a short time lapse to learn more about the nature of the Atg9–Arp2 interaction. Each projected image shown is a sum projection of Z-sections. We saw that in the wild-type strain an individual Atg9-3xGFP punctum momentarily coincided with an Arp2-3xDsRed dot usually for <10 s, although we occasionally detected colocalization for more than 10 s (Figure 6B). In contrast, in cells expressing the mutant Atg9H192L-3xGFP, dots rarely coincided with Arp2. Quantification of the results revealed that colocalization was significantly reduced with the Atg9H192L mutant, which is consistent with our coimmunoprecipitation results (Figure 6C).
|
|
|
Finally, we examined mutant forms of two proteins that regulate the activity of the Arp2/3 complex, Las17 and Pan1. Both the pan1-3 and las17-11 mutants displayed normal processing of prApe1 (Figure 8C); however, these two proteins are partially redundant in function (Toshima et al., 2005
). Therefore, we next examined versions of these proteins that are defective for activating and/or binding the Arp2/3 complex (Toshima et al., 2005
). The las17
WCA mutant displayed an
50% block in prApe1 maturation, whereas the double las17
WCA pan1
855-1480 mutant was completely defective for the Cvt pathway based on prApe1 processing (Figure 8C). Overall, these results suggest that the function of the Arp2/3 complex is required particularly for selective autophagy.
| DISCUSSION |
|---|
|
|
|---|
Atg9 Cycling Is Regulated by Arp2 during Selective Autophagy
Unlike other intracellular trafficking mechanisms, autophagy uses double-membrane vesicles that are formed de novo. One of the most important questions concerning autophagy is the mechanism used to compose the autophagosomes, and the source of the lipids that supply the site of autophagosome assembly, the PAS. Atg9, is a transmembrane protein that cycles between peripheral structures and the PAS, and it is therefore proposed to play a key role in membrane delivery during the assembly process (Reggiori and Klionsky, 2005
). Transfer of Atg9 to the cargo site involves Atg11, Atg23, Atg27, and actin (He et al., 2006
, Legakis et al., 2007
, Yen et al., 2007
); however, the mechanism by which actin mediates Atg9 anterograde movement is not known. We found that in arp2-1 mutant cells, Atg9 movement was severely compromised; Atg9 was unable to colocalize with the PAS marker prApe1, suggesting a role for Arp2 in directing or regulating Atg9 anterograde movement to the PAS (Figure 2).
Real-time analysis of Atg9 dynamics in arp2-1 cells revealed that patches of Atg9 located at the peripheral sites are immobile, in contrast to their rapid movement in wild-type cells, implying that Arp2 is required for Atg9 movement (Figure 3). These data suggest that Arp2, presumably in conjunction with other subunits of the Arp2/3 complex, may function in some aspect of vesicle movement involving Atg9, by analogy with the role of Arp2 in other processes involving membrane movement such as endocytosis (Liu et al., 2006
, Takenawa and Suetsugu, 2007
). The components of the Arp2/3 complex display transient interaction with forming endocytic vesicles. Accordingly, we examined potential interactions between Atg9 and Arp2.
Using real-time three-dimensional (4D)-microscopy, we found that Atg9 and Arp2 display transient colocalization (Figure 4). We used affinity isolation to verify that the colocalization corresponded to an actual interaction (Figure 5). These events most likely take place at the peripheral patches where Atg9 colocalizes with Arp2 but not at the PAS, which is the ultimate destination, because we did not detect colocalization or direct interaction between these two proteins in an atg1
mutant where Atg9 is confined to the PAS (Figures 4 and 5). There was also a lack of interaction between Atg9 and Arp2 in an atg11
strain or in an Atg11 mutant that is defective in binding Atg9 (Figure 6), even though Atg9 is restricted to the peripheral sites in this mutant. Therefore, this result suggests that Atg11 may directly or indirectly mediate the interaction between Atg9 and Arp2. In contrast to the results with the atg11
strain, Atg9 still interacts with the arp2-1 mutant protein, even at the nonpermissive temperature (Figure 7). Therefore, lack of movement in the arp2-1 mutant does not reflect an inability of Atg9 to interact with arp2-1, but rather it is due to the defect in the function of the arp2-1 protein. These data support a model where actin nucleation events direct the movement of Atg9 from peripheral sites to allow the delivery of membranes to the cargo, and expansion of the forming autophagosome under vegetative growth conditions.
How Does Arp2/3 Function in Selective Autophagy?
Arp2/3 and its activators such as Las17 (the yeast homologue of the Wiskott–Aldrich syndrome protein, N-WASP), possibly in complex with the type 1 myosins Myo3 and Myo5, Abp1, or Pan1 initiate the assembly of actin filaments (Pollard, 2007
, Winder and Ayscough, 2005
). This proceeds in such a way that actin monomers (Act1) are added to the barbed ends of the Arp2 and Arp3 subunits of the Arp2/3 complex. Arp2 and Arp3 have a tertiary structure similar to that of actin itself. Thus, when the Arp2/3 complex binds the first actin monomer, it allows creation of the nucleus, which is a growing end during actin filament elongation. This growing end of the filament is directed toward a membrane surface, the specific place where a vesicle will bud off. For example, during endocytosis the elongation of growing actin filaments pushes against the plasma membrane, providing the driving force that results in membrane invagination and subsequent vesicle propulsion, eventually leading to vesicle scission and movement away from the donor membrane (Ayscough, 2005
, Takenawa and Suetsugu, 2007
).
We propose that during autophagy the Arp2/3 complex functions in a similar manner, providing the force that is required for anterograde Atg9 movement. The Arp2/3 proteins may allow Atg9 and associated membrane to "bud" off the membrane source at the peripheral sites. As a result, Atg9 is directed in an Atg11-, Atg23- and Atg27-dependent mechanism, presumably along actin cables, to the prApe1 cargo at the PAS. The specific autophagy factors such as Atg19 and Atg11, and perhaps other molecular components, serve as adaptors between the Cvt cargo and the actin cytoskeleton. We are just beginning to understand the mechanism of Atg9 trafficking. Our knowledge primarily derives from studies in yeast; however, it is worth noting that the Arp2/3 complex, its activators and Atg9 are highly conserved through all eukaryotes, including humans. Not much is known about the relationship between the actin cytoskeleton and autophagy in higher eukaryotic systems. Further analysis of Atg9 cycling and its interactions with actin-binding proteins, will unravel the essential mechanisms of cytoskeleton function in specific types of autophagy.
| ACKNOWLEDGMENTS |
|---|
| Footnotes |
|---|
Address correspondence to: Daniel J. Klionsky (klionsky{at}umich.edu)
Abbreviations used: Atg, autophagy-related; Cvt, cytoplasm to vacuole targeting; GFP, green fluorescent protein; PAS, phagophore assembly site; prApe1, precursor aminopeptidase I; TR phalloidin, Texas Red-X phalloidin; ts, temperature sensitive.
| REFERENCES |
|---|
|
|
|---|
Aplin, A., Jasionowski, T., Tuttle, D. L., Lenk, S. E., and Dunn, W. A., Jr. (1992). Cytoskeletal elements are required for the formation and maturation of autophagic vacuoles. J. Cell. Physiol 152, 458–466.[CrossRef][Medline]
Ayscough, K. R. (2005). Coupling actin dynamics to the endocytic process in Saccharomyces cerevisiae. Protoplasma 226, 81–88.[CrossRef][Medline]
Baba, M., Osumi, M., Scott, S. V., Klionsky, D. J., and Ohsumi, Y. (1997). Two distinct pathways for targeting proteins from the cytoplasm to the vacuole/lysosome. J. Cell Biol 139, 1687–1695.
Birmingham, C. L., and Brumell, J. H. (2006). Autophagy recognizes intracellular Salmonella enterica serovar Typhimurium in damaged vacuoles. Autophagy 2, 156–158.[Medline]
Boldogh, I. R., Nowakowski, D. W., Yang, H. C., Chung, H., Karmon, S., Royes, P., and Pon, L. A. (2003). A protein complex containing Mdm10p, Mdm12p, and Mmm1p links mitochondrial membranes and DNA to the cytoskeleton-based segregation machinery. Mol. Biol. Cell 14, 4618–4627.
Boldogh, I. R., Yang, H. C., Nowakowski, W. D., Karmon, S. L., Hays, L. G., Yates, J. R., III, and Pon, L. A. (2001). Arp2/3 complex and actin dynamics are required for actin-based mitochondrial motility in yeast. Proc. Natl. Acad. Sci. USA 98, 3162–3167.
Boyd, C., Hughes, T., Pypaert, M., and Novick, P. (2004). Vesicles carry most exocyst subunits to exocytic sites marked by the remaining two subunits, Sec3p and Exo70p. J. Cell Biol 167, 889–901.
Cheong, H., Yorimitsu, T., Reggiori, F., Legakis, J. E., Wang, C.-W., and Klionsky, D. J. (2005). Atg17 regulates the magnitude of the autophagic response. Mol. Biol. Cell 16, 3438–3453.
Colombo, M. I., Gutierrez, M. G., and Romano, P. S. (2006). The two faces of autophagy: Coxiella and Mycobacterium. Autophagy 2, 162–164.[Medline]
D'Agostino, J. L., and Goode, B. L. (2005). Dissection of Arp2/3 complex actin nucleation mechanism and distinct roles for its nucleation-promoting factors in Saccharomyces cerevisiae. Genetics 171, 35–47.
Duncan, M. C., Cope, M. J., Goode, B. L., Wendland, B., and Drubin, D. G. (2001). Yeast Eps15-like endocytic protein, Pan1p, activates the Arp2/3 complex. Nat. Cell Biol 3, 687–690.[CrossRef][Medline]
Dunn, W. A., Jr, Cregg, J. M., Kiel, J. A. K. W., van der Klei, I. J., Oku, M., Sakai, Y., Sibirny, A. A., Stasyk, O. V., and Veenhuis, M. (2005). Pexophagy: the selective autophagy of peroxisomes. Autophagy 1, 75–83.[Medline]
Fehrenbacher, K. L., Yang, H. C., Gay, A. C., Huckaba, T. M., and Pon, L. A. (2004). Live cell imaging of mitochondrial movement along actin cables in budding yeast. Curr. Biol 14, 1996–2004.[CrossRef][Medline]
Guan, J., Stromhaug, P. E., George, M. D., Habibzadegah-Tari, P., Bevan, A., Dunn, W. A., Jr, and Klionsky, D. J. (2001). Cvt18/Gsa12 is required for cytoplasm-to-vacuole transport, pexophagy, and autophagy in Saccharomyces cerevisiae and Pichia pastoris. Mol. Biol. Cell 12, 3821–3838.
Hamasaki, M., Noda, T., Baba, M., and Ohsumi, Y. (2005). Starvation triggers the delivery of the endoplasmic reticulum to the vacuole via autophagy in yeast. Traffic 6, 56–65.[CrossRef][Medline]
He, C., Song, H., Yorimitsu, T., Monastyrska, I., Yen, W.-L., Legakis, J. E., and Klionsky, D. J. (2006). Recruitment of Atg9 to the preautophagosomal structure by Atg11 is essential for selective autophagy in budding yeast. J. Cell Biol 175, 925–935.
James, P., Halladay, J., and Craig, E. A. (1996). Genomic libraries and a host strain designed for highly efficient two-hybrid selection in yeast. Genetics 144, 1425–1436.[Abstract]
Kim, J., Huang, W.-P., and Klionsky, D. J. (2001). Membrane recruitment of Aut7p in the autophagy and cytoplasm to vacuole targeting pathways requires Aut1p, Aut2p, and the autophagy conjugation complex. J. Cell Biol 152, 51–64.
Kissova, I., Salin, B., Schaeffer, J., Bhatia, S., Manon, S., and Camougrand, N. (2007). Selective and non-selective autophagic degradation of mitochondria in yeast. Autophagy 3, 329–336.[Medline]
Klionsky, D. J. (2005). Autophagy. Curr. Biol 15, R282–R283.[Medline]
Klionsky, D. J. et al. (2003). A unified nomenclature for yeast autophagy-related genes. Dev. Cell 5, 539–545.[CrossRef][Medline]
Klionsky, D. J., Cueva, R., and Yaver, D. S. (1992). Aminopeptidase I of Saccharomyces cerevisiae is localized to the vacuole independent of the secretory pathway. J. Cell Biol 119, 287–299.
Legakis, J. E., Yen, W.-L., and Klionsky, D. J. (2007). A cycling protein complex required for selective autophagy. Autophagy 3, 422–432.[Medline]
Levine, B., and Klionsky, D. J. (2004). Development by self-digestion: molecular mechanisms and biological functions of autophagy. Dev. Cell 6, 463–477.[CrossRef][Medline]
Liu, J., Kaksonen, M., Drubin, D. G., and Oster, G. (2006). Endocytic vesicle scission by lipid phase boundary forces. Proc. Natl. Acad. Sci. USA 103, 10277–10282.
Longtine, M. S., McKenzie, A., III, Demarini, D. J., Shah, N. G., Wach, A., Brachat, A., Philippsen, P., and Pringle, J. R. (1998). Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14, 953–961.[CrossRef][Medline]
Mizushima, N., and Klionsky, D. J. (2007). Protein turnover via autophagy: implications for metabolism. Annu. Rev. Nutr 27, 19–40.[CrossRef][Medline]
Moreau, V., Galan, J. M., Devilliers, G., Haguenauer-Tsapis, R., and Winsor, B. (1997). The yeast actin-related protein Arp2p is required for the internalization step of endocytosis. Mol. Biol. Cell 8, 1361–1375.[Abstract]
Pinyol, R., Haeckel, A., Ritter, A., Qualmann, B., and Kessels, M. M. (2007). Regulation of N-wasp and the Arp2/3 complex by abp1 controls neuronal morphology. PLoS ONE 2, e400.[CrossRef]
Pollard, T. D. (2007). Regulation of actin filament assembly by Arp2/3 complex and formins. Annu. Rev. Biophys. Biomol. Struct 36, 451–477.[CrossRef][Medline]
Reggiori, F., and Klionsky, D. J. (2005). Autophagosomes: biogenesis from scratch? Curr. Opin. Cell Biol 17, 415–422.[CrossRef][Medline]
Reggiori, F., Monastyrska, L., Shintani, T., and Klionsky, D. J. (2005a). The actin cytoskeleton is required for selective types of autophagy, but not nonspecific autophagy, in the yeast Saccharomyces cerevisiae. Mol. Biol. Cell 16, 5843–5856.
Reggiori, F., and Pelham, H.R.B. (2001). Sorting of proteins into multivesicular bodies: ubiquitin-dependent and -independent targeting. EMBO J 20, 5176–5186.[CrossRef][Medline]
Reggiori, F., Shintani, T., Nair, U., and Klionsky, D. J. (2005b). Atg9 cycles between mitochondria and the pre-autophagosomal structure in yeasts. Autophagy 1, 101–109.[Medline]
Robinson, J. S., Klionsky, D. J., Banta, L. M., and Emr, S. D. (1988). Protein sorting in Saccharomyces cerevisiae: isolation of mutants defective in the delivery and processing of multiple vacuolar hydrolases. Mol. Cell. Biol 8, 4936–4948.
Rubinsztein, D. C., Gestwicki, J. E., Murphy, L. O., and Klionsky, D. J. (2007). Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov 6, 304–312.[CrossRef][Medline]
Scott, S. V., Baba, M., Ohsumi, Y., and Klionsky, D. J. (1997). Aminopeptidase I is targeted to the vacuole by a nonclassical vesicular mechanism. J. Cell Biol 138, 37–44.
Seglen, P. O., Berg, T. O., Blankson, H., Fengsrud, M., Holen, I., and Stromhaug, P. E. (1996). Structural aspects of autophagy. Adv. Exp. Med. Biol 389, 103–111.[Medline]
Shintani, T., Huang, W.-P., Stromhaug, P. E., and Klionsky, D. J. (2002). Mechanism of cargo selection in the cytoplasm to vacuole targeting pathway. Dev. Cell 3, 825–837.[CrossRef][Medline]
Shintani, T., and Klionsky, D. J. (2004a). Autophagy in health and disease: a double-edged sword. Science 306, 990–995.
Shintani, T., and Klionsky, D. J. (2004b). Cargo proteins facilit